plasmodium-vivax

Documents about plasmodium-vivax

• A Retrospective Study of Severe Plasmodium Vivax#1074289ClinicalTrials.gov
• DSM265 Phase IIa Investigation Treating Plasmodium Falciparum or Vivax#1384560ClinicalTrials.gov
• Effect of Liver and Blood-stage Treatment on Subsequent Plasmodium Reinfection and Morbidity#898898ClinicalTrials.gov
• The Plasmodium vivax rhoptry neck protein 5 is expressed in the apical pole of Plasmodium vivax VCG-1 strain schizonts and binds to human reticulocytes#236936Repositorio institucional EdocUR
• Comparative Study of Thrombocytopenia in Plasmodium Vivax and Falciparum Malaria#835482ClinicalTrials.gov
• Serological Testing and Treatment for Plasmodium Vivax Malaria: a Trial in Ethiopia and Madagascar#1307874ClinicalTrials.gov
• A Pharmacokinetics, Safety and Efficacy Study of Tafenoquine (TQ) in Pediatric Subjects With Plasmodium Vivax (P. Vivax) Malaria#1184238ClinicalTrials.gov
• Genomic Insights Into Host Shifts Between Plasmodium vivax and Plasmodium simium in Latin America#330111HAL (France)
• Tafenoquine Combinations for Improved Radical Cure Efficacy of Plasmodium Vivax#869261ClinicalTrials.gov
• Study of Controlled Human Plasmodium Vivax Infection#1321647ClinicalTrials.gov
• Pilot Human Study of Tinidazole Efficacy For Radical Cure Of Plasmodium Vivax#897723ClinicalTrials.gov
• Antimalarial Drug Susceptibility and Molecular Characterization of Plasmodium Vivax Isolates in Vietnam#1475442ClinicalTrials.gov
• Estimating the Risk of Plasmodium Vivax Relapses in Afghanistan#914822ClinicalTrials.gov
• Vivax Malaria Human Infection Studies in Thailand#1171118ClinicalTrials.gov
• Primaquine Double Dose for Radical Cure of Plasmodium Vivax in Colombia#829839ClinicalTrials.gov
• Clinical Trial to Evaluate the Safety and Immunogenicity of the Vivaxin Vaccine for Malaria Caused by Plasmodium Vivax."#1150174ClinicalTrials.gov
• Malaria#342763Repositorio de datos de investigación de la Universidad de Chile Dataverse OAI Archive
• Efficacy and Safety Study of Tafenoquine (TQ) Co-administered With Dihydroartemisinin-piperaquine (DHA-PQP) for the Radical Cure of Plasmodium Vivax (P. Vivax) Malaria#803877ClinicalTrials.gov
• P.Vivax Treatment Trial#1323028ClinicalTrials.gov
• Study of ACTs Plus Primaquine for Uncomplicated Plasmodium Vivax Malaria#1466251ClinicalTrials.gov
• Efficacy of Focal Primaquine Mass Administration for Eliminating Plasmodium Vivax Malaria in Northern Myanmar#876376ClinicalTrials.gov
• Malaria Genetic Surveillance#1009447ClinicalTrials.gov
• Prise en charge des cas de paludisme à Plasmodium vivax : un guide de terrain#296423WHO IRIS
• Understanding Plasmodium vivax recurrent infections using an amplicon deep sequencing assay, identity-by-descent and model-based classification#147464HAL (France)
• Phase IIa/b Trial of PvCS/Montanide ISA-51 Malaria Vaccine in Adults in Chocó, Colombia#366655ClinicalTrials.gov
• Malaria Prevention Cambodia#1429970ClinicalTrials.gov
• ACT vs CQ With Tafenoquine for P. Vivax Mono-infection#1365200ClinicalTrials.gov
• Study to Assess the Incidence of Hemolysis, Safety, and Efficacy of Tafenoquine (SB-252263, WR238605) Versus Primaquine in Subjects With Plasmodium Vivax Malaria#1310076ClinicalTrials.gov
• Establishment of a Sporozoite Challenge Model for Plasmodium Vivax in Human Volunteers#184940ClinicalTrials.gov
• Clinical Study to Assess Minimum Mosquito Bites for P. Vivax Infection in Thai Adults#387198ClinicalTrials.gov
• Plasmodium vivax Transmission in Africa.#20032DOAJ
• Assessment of Any Potential Retinal Effects of Tafenoquine (TQ)#1228106ClinicalTrials.gov
• Effectiveness of Novel Approaches to Radical Cure With Tafenoquine and Primaquine#1073082ClinicalTrials.gov
• Prevention of P. Vivax Malaria During Pregnancy in Bolivia#1453866ClinicalTrials.gov
• PpPfs25/ISA51 and ScPvs25/ISA51 Vaccines for Malaria#146245ClinicalTrials.gov
• YAT2150 is irresistible in Plasmodium falciparum and active against Plasmodium vivax and Leishmania clinical isolates#205757HAL (France)
• Comparable severity of <i>Plasmodium vivax</i> and <i>Plasmodium falciparum</i> malaria in hospitalized patients in the Peruvian Amazon#1038712Europe PMC
• Comparison of Two Antimalarial Drugs Regimens in Patient With Plasmodium Vivax Malaria in Thailand#1211793ClinicalTrials.gov
• Splenectomised and spleen intact Aotus monkeys'immune response to Plasmodium vivax MSP-1 protein fragments and their high activity binding peptides.#396873Repositorio institucional EdocUR
• Application of 23 Novel Serological Markers for Identifying Recent Exposure to Plasmodium vivax Parasites in an Endemic Population of Western Thailand#1054563Open Research
• A Controlled Human Vivax Malaria Infection Study Through Inoculation of Infected Erythrocytes#805385ClinicalTrials.gov
• Immunogenetic markers associated with a naturally acquired humoral immune response against an N-terminal antigen of Plasmodium vivax merozoite surface protein 1 (PvMSP-1)#345453Repositório Institucional da Universidade Federal de Sergipe
• The Malaria Heart Disease Study#1096525ClinicalTrials.gov
• Therapeutic Efficacy of Chloroquine Plus Primaquine in the Treatment of Uncomplicated Plasmodium Vivax#1111984ClinicalTrials.gov
• TES of Chloroquine for Pv in the Philippines in 2016#1497183ClinicalTrials.gov
• Plasmodium Immunotherapy for Lung Cancer#1419613ClinicalTrials.gov
• Self-assembling functional programmable protein array for studying protein-protein interactions in malaria parasites#236920Repositorio institucional EdocUR
• Pv3Rs: Plasmodium vivax relapse, recrudescence, and reinfection statistical genetic inference#268673HAL (France)
• Targeting High Risk Populations With Enhanced Reactive Focal Mass Drug Administration in Thailand#1182917ClinicalTrials.gov
• Operational Feasibility of Appropriate Plasmodium Vivax Radical Cure After G6PD Testing in Thailand#1244684ClinicalTrials.gov